Literature DB >> 22397948

Dynamics of receptor trafficking in tumorigenicity.

Christine A Parachoniak1, Morag Park.   

Abstract

The transport and sorting of cell surface receptors into membrane-bound intracellular compartments is crucial for cellular homeostasis. Defects in receptor trafficking are associated with several diseases, including cancer. Recent advances in our understanding of mechanisms that control receptor trafficking have highlighted the involvement of membrane trafficking in cell signaling, as well as in biological processes, including cell migration and invasion. In this review, we summarize current knowledge of how cargos, focusing on receptor tyrosine kinases (RTKs) and integrins, are dynamically transported through the endosomal pathway for recycling, and how this promotes spatially restricted signaling microdomains associated with distinct biological responses. We discuss mechanisms through which dysregulation of membrane trafficking contributes to tumorigenesis and potential therapeutic approaches.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22397948     DOI: 10.1016/j.tcb.2012.02.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  29 in total

1.  Protein trafficking abnormalities in Drosophila tissues with impaired activity of the ZIP7 zinc transporter Catsup.

Authors:  Casper Groth; Takeshi Sasamura; Mansi R Khanna; Michael Whitley; Mark E Fortini
Journal:  Development       Date:  2013-06-19       Impact factor: 6.868

2.  Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.

Authors:  Adrienne C Greene; Samuel J Lord; Aiwei Tian; Christopher Rhodes; Hiroyuki Kai; Jay T Groves
Journal:  Biophys J       Date:  2014-05-20       Impact factor: 4.033

Review 3.  Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.

Authors:  R L Juliano; K Carver; C Cao; X Ming
Journal:  J Drug Target       Date:  2012-11-19       Impact factor: 5.121

Review 4.  Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity.

Authors:  Patricia L M Dahia
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

5.  RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.

Authors:  Eric Y Lian; Brandy D Hyndman; Serisha Moodley; Sarah M Maritan; Lois M Mulligan
Journal:  Oncogene       Date:  2020-09-03       Impact factor: 9.867

6.  Combining confocal and atomic force microscopy to quantify single-virus binding to mammalian cell surfaces.

Authors:  Richard Newton; Martin Delguste; Melanie Koehler; Andra C Dumitru; Pawel R Laskowski; Daniel J Müller; David Alsteens
Journal:  Nat Protoc       Date:  2017-10-05       Impact factor: 13.491

7.  GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.

Authors:  Qing-Hai Ye; Wen-Wei Zhu; Ju-Bo Zhang; Yi Qin; Ming Lu; Guo-Ling Lin; Lei Guo; Bo Zhang; Zhen-Hai Lin; Stephanie Roessler; Marshonna Forgues; Hu-Liang Jia; Lu Lu; Xiao-Fei Zhang; Bao-Feng Lian; Lu Xie; Qiong-Zhu Dong; Zhao-You Tang; Xin Wei Wang; Lun-Xiu Qin
Journal:  Cancer Cell       Date:  2016-08-25       Impact factor: 31.743

Review 8.  Endocytosis and cancer.

Authors:  Ira Mellman; Yosef Yarden
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

9.  Complex Rab4-Mediated Regulation of Endosomal Size and EGFR Activation.

Authors:  Kate Tubbesing; Jamie Ward; Raymond Abini-Agbomson; Aditi Malhotra; Alena Rudkouskaya; Janine Warren; John Lamar; Nina Martino; Alejandro P Adam; Margarida Barroso
Journal:  Mol Cancer Res       Date:  2020-02-04       Impact factor: 5.852

10.  Altered endosome biogenesis in prostate cancer has biomarker potential.

Authors:  Ian R D Johnson; Emma J Parkinson-Lawrence; Tetyana Shandala; Roberto Weigert; Lisa M Butler; Doug A Brooks
Journal:  Mol Cancer Res       Date:  2014-07-30       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.